Literature DB >> 8467820

Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production.

K Blennow1, P Fredman, A Wallin, C G Gottfries, I Skoog, C Wikkelsö, L Svennerholm.   

Abstract

To examine the possible influence of the blood-CSF barrier function on mathematical formulas for estimating intrathecal IgG production (IgG index, Tourtellotte's formula [TOURT], Schuller and Sagar's formula [Schull], and Reiber and Felgenhauer's formula [IgG(loc)]), we analysed serum and CSF samples from 105 healthy individuals, aged 18-88 years, and 816 consecutive patients without oligoclonal IgG bands (OCBs) in the CSF, aged 18-91 years. In healthy individuals there was no significant correlation between the CSF/serum (S) albumin ratio (i.e. blood-CSF barrier function) and the IgG index, a dimensionless quotient for determining intrathecal IgG production, and only a small correlation (r = -0.08, p < 0.05) in patients without OCBs. However, significant dependence on the blood-CSF barrier function was found, in both healthy individuals and patients without OCBs, for the formulas determining intrathecal IgG production in milligrams (per litre CSF or per day), i.e. for TOURT, SCHULL and IgG(loc). Therefore, we propose a new formula for the quantitative determination of intrathecal IgG production in mg/l, the IGGPROD, which is calculated as: CSF-IgG -[(0.51 x CSF-Alb x S-IgG)/S-Alb]. IGGPROD is an empirical formula, based on findings in 105 healthy individuals 18-88 years of age, and does not depend on the blood CSF barrier function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467820     DOI: 10.1159/000116920

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  9 in total

Review 1.  Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

Authors:  Nenad Vasic; Bernhard J Connemann; Robert C Wolf; Hayrettin Tumani; Johannes Brettschneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-16       Impact factor: 5.270

Review 2.  Proteomics of human neurodegenerative diseases.

Authors:  Jing Zhang; C Dirk Keene; Catherine Pan; Kathleen S Montine; Thomas J Montine
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

3.  Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

Authors:  Michael P Pender; Peter A Csurhes; Corey Smith; Nanette L Douglas; Michelle A Neller; Katherine K Matthews; Leone Beagley; Sweera Rehan; Pauline Crooks; Tracey J Hopkins; Stefan Blum; Kerryn A Green; Zara A Ioannides; Andrew Swayne; Blake T Aftab; Kaye D Hooper; Scott R Burrows; Kate M Thompson; Alan Coulthard; Rajiv Khanna
Journal:  JCI Insight       Date:  2018-11-15

4.  Cerebrospinal Fluid Pathologies in Schizophrenia-Spectrum Disorder-A Retrospective Chart Review.

Authors:  Mattia Campana; Johanna Strauß; Susanne Münz; Tatiana Oviedo-Salcedo; Piyumi Fernando; Peter Eichhorn; Peter Falkai; Alkomiet Hasan; Elias Wagner
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

Review 5.  Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms.

Authors:  Linnea R Freeman; Vivian Haley-Zitlin; Dorothea S Rosenberger; Ann-Charlotte Granholm
Journal:  Nutr Neurosci       Date:  2013-11-26       Impact factor: 4.994

6.  Cerebrospinal Fluid and Plasma Lipopolysaccharide Levels in Human Immunodeficiency Virus Type 1 Infection and Associations With Inflammation, Blood-Brain Barrier Permeability, and Neuronal Injury.

Authors:  Wei Jiang; Zhenwu Luo; Sophie Stephenson; Hong Li; Clara Di Germanio; Philip J Norris; Dietmar Fuchs; Henrik Zetterberg; Magnus Gisslen; Richard W Price
Journal:  J Infect Dis       Date:  2021-05-20       Impact factor: 5.226

7.  IgG intrathecal synthesis in HIV-associated neurocognitive disorder (HAND) according to the HIV-1 subtypes and pattern of HIV RNA in CNS and plasma compartments.

Authors:  Sergio M De Almeida; Indianara Rotta; Bin Tang; Florin Vaida; Scott Letendre; Ronald J Ellis
Journal:  J Neuroimmunol       Date:  2021-03-08       Impact factor: 3.221

8.  Cerebrospinal fluid findings in patients with psychotic symptoms-a retrospective analysis.

Authors:  Tim W Rattay; Pascal Martin; Debora Vittore; Holger Hengel; Idil Cebi; Johannes Tünnerhoff; Maria-Ioanna Stefanou; Jonatan F Hoffmann; Katrin von der Ehe; Johannes Klaus; Julia Vonderschmitt; Matthias L Herrmann; Paula Bombach; Hazar Al Barazi; Lena Zeltner; Janina Richter; Klaus Hesse; Kathrin N Eckstein; Stefan Klingberg; Dirk Wildgruber
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

9.  Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19.

Authors:  Alexandra C Apple; Alexis Oddi; Michael J Peluso; Breton M Asken; Timothy J Henrich; J Daniel Kelly; Samuel J Pleasure; Steven G Deeks; Isabel Elaine Allen; Jeffrey N Martin; Lishomwa C Ndhlovu; Bruce L Miller; Melanie L Stephens; Joanna Hellmuth
Journal:  Ann Clin Transl Neurol       Date:  2022-01-19       Impact factor: 5.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.